These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20947393)

  • 1. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
    Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
    Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
    Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
    Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
    Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
    Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.
    Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S
    Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.
    Dutra AP; Granja NV; Schmitt FC; Cassali GD
    Braz J Med Biol Res; 2004 Nov; 37(11):1673-81. PubMed ID: 15517084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis.
    Gärtner F; Geraldes M; Cassali G; Rema A; Schmitt F
    Vet J; 1999 Jul; 158(1):39-47. PubMed ID: 10409415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In pursuit of a prognostic marker in canine mammary tumors.
    Miller MA; Mohammed SI
    Vet J; 2011 Sep; 189(3):245. PubMed ID: 21277242
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
    Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
    J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
    Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
    Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
    Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
    J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
    Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
    Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.
    Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A
    Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.